Opus Genetics, Inc., a pharmaceutical company specializing in preparations with a market capitalization of $35.67 million, has announced the date for its 2025 Annual Meeting of Stockholders. According ...

BROWNSVILLE — It was an unusually cold Saturday morning in the Rio Grande Valley but that didn't stop hundreds of people from forming a line that wound throughout the south side of the Brownsville ...

Amgen (AMGN) ended the recent trading session at $277.88, demonstrating a +1.62% swing from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily gain of 0.53 ...